Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy

Table 4 Univarite and multivariate analysis of risk factors for overall survival following GBNAT and surgical resection

Parameter	Univariate	Multivariate
	P	OR	95% CI	P
Age	0.308	0.982	0.891-1.082	0.709
Tumor location: head or body vs tail	0.003	4.689	0.048-458.2	0.509
Resectable operation: resectable vs non-resectable	0.001	5.492	0.122-246.7	0.380
CEA: post-op <6 vs >6	0.059	0.054	0.005-0.631	0.020
CA 199: pre-GBNAT <294 vs >294	0.011	0.033	0.002-0.522	0.015
CA 199: post-GBNAT <152 vs >152	0.008	0.464	0.041-5.672	0.536
CA 199: post-op <82 vs >82	0.000	0.201	0.015-2.652	0.223
CA125: post-GBNAT <32.8 vs >32.8	0.018	0.034	0.003-0.372	0.006

Abbreviations: OR odds ratio, 95% CI 95% confidence interval. Bold letter means the p-values less than 0.05.

ISSN: 1471-2482